Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

On Wednesday, the US Supreme Court agreed to hear US Food and Drug Administration v. Alliance for Hippocratic Medicine, the case that will determine the accessibility of mifepristone, one of the two primary medications used in medication abortion. This decision ensures that, for now, mifepristone will continue to be available in states where abortion is legal.

Mifepristone is an extremely safe, effective medication that has been used for both abortion and miscarriage care since the FDA first approved it more than 23 years ago. Patients deserve to access the medication they need to manage their reproductive health safely and on their own terms. Health care providers should be able to provide mifepristone without unnecessary interference from courts or politicians.

It is imperative for the Supreme Court to reject this politically motivated attempt to interfere with the FDA’s approval process. These efforts seek to reinstate unnecessary restrictions to mifepristone and limit access to medication abortion nationwide, jeopardizing the health and well-being of those seeking essential medical care.

Make no mistake, the repercussions of this case go far beyond abortion care — they could upend the country’s drug approval process, and put every FDA-approved medication at risk of being restricted to advance a political agenda. We should never be in a position where judges are deciding whether people can get safe, effective medicines.

Planned Parenthood of Southern New England continues to provide medication abortion as an option for eligible patients seeking abortion care in Connecticut and Rhode Island and as always, will follow evidence-based standards to provide safe, high-quality abortion care consistent with all state and federal regulations. We will never stop fighting to make sure patients have access to the essential health care that they need.

__________

Amanda Skinner is the president and CEO of Planned Parenthood of Southern New England.

Published in the Boston Globe on December 14, 2023.

Tags: Abortion, Supreme Court, mifepristone

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.